» Articles » PMID: 27334784

Periostin and Interleukin-13 Are Independently Related to Chronic Spontaneous Urticaria

Overview
Date 2016 Jun 24
PMID 27334784
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic spontaneous urticaria (CSU) is a complex idiopathic disease of the skin with various cellular infiltrations. Although mast cells are key effector cells in the pathogenesis of CSU, CD4+ T helper 2 cells also have particular roles in the development and maintenance of CSU. Periostin is known as a downstream molecule of interleukin (IL)-4 and IL-13, key cytokines of type 2 immune responses. In this study, we examined periostin and IL-13 levels in the sera of patients with CSU (n=84) and healthy normal controls (NCs, n=43). Periostin levels were significantly lower in the CSU group than in NCs (71.4±21.8 vs 85.1±22.4 ng/mL, P=0.04). Periostin levels were also lower in the severe CSU group than those in mild CSU (59.7±18.0 vs 73.4±22.0 ng/mL, P=0.04). However, IL-13 levels were significantly higher in patients with CSU than in NCs (508.5±51.2 vs 200.7±13.3 pg/mL, P=0.001). In conclusion, periostin and IL-13 may be independently related to the pathogenesis of CSU.

Citing Articles

Atopy in chronic urticaria: an important yet overlooked issue.

Chen Q, Yang X, Ni B, Song Z Front Immunol. 2024; 15:1279976.

PMID: 38380314 PMC: 10876790. DOI: 10.3389/fimmu.2024.1279976.


Identification of Immune Cell-Types and Pathways Involved in Chronic Spontaneous Urticaria.

Prosty C, Gabrielli S, Ben-Shoshan M, Le M, Gimenez-Arnau A, Litvinov I Front Med (Lausanne). 2022; 9:926753.

PMID: 35872776 PMC: 9302568. DOI: 10.3389/fmed.2022.926753.


The Role of Crosstalk of Immune Cells in Pathogenesis of Chronic Spontaneous Urticaria.

Zhou B, Li J, Liu R, Zhu L, Peng C Front Immunol. 2022; 13:879754.

PMID: 35711438 PMC: 9193815. DOI: 10.3389/fimmu.2022.879754.


Exhaled Nitric Oxide Level in Pharynx Angioedema.

Moos L, Zajac M, Brzoza Z J Clin Med. 2022; 11(3).

PMID: 35160089 PMC: 8836686. DOI: 10.3390/jcm11030637.


Periostin in Allergy and Inflammation.

Sonnenberg-Riethmacher E, Miehe M, Riethmacher D Front Immunol. 2021; 12:722170.

PMID: 34512647 PMC: 8429843. DOI: 10.3389/fimmu.2021.722170.


References
1.
Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S . Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006; 118(1):98-104. DOI: 10.1016/j.jaci.2006.02.046. View

2.
Wenzel S . Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012; 18(5):716-25. DOI: 10.1038/nm.2678. View

3.
Zweiman B, Haralabatos I, Pham N, David M, von Allmen C . Sequential patterns of inflammatory events during developing and expressed skin late-phase reactions. J Allergy Clin Immunol. 2000; 105(4):776-81. DOI: 10.1067/mai.2000.105223. View

4.
Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica G . Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2014; 69(7):e1-29. DOI: 10.1111/all.12370. View

5.
Caproni M, Cardinali C, Giomi B, Antiga E, DAgata A, Walter S . Serological detection of eotaxin, IL-4, IL-13, IFN-gamma, MIP-1alpha, TARC and IP-10 in chronic autoimmune urticaria and chronic idiopathic urticaria. J Dermatol Sci. 2004; 36(1):57-9. DOI: 10.1016/j.jdermsci.2004.07.006. View